Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.49B | 1.91B | 1.58B | 1.32B | 1.28B | 1.07B | Gross Profit |
360.75M | 268.70M | 229.00M | 178.80M | 189.90M | 170.90M | EBIT |
256.70M | 192.50M | 172.80M | 117.50M | 112.30M | 117.60M | EBITDA |
384.85M | 290.90M | 261.70M | 183.60M | 205.10M | 179.00M | Net Income Common Stockholders |
176.85M | 139.60M | 154.40M | 90.00M | 121.70M | 106.30M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
231.00M | 231.00M | 156.90M | 248.70M | 191.00M | 105.80M | Total Assets |
2.11B | 2.11B | 2.07B | 1.76B | 1.49B | 1.44B | Total Debt |
391.80M | 391.80M | 368.90M | 22.10M | 26.70M | 27.90M | Net Debt |
160.80M | 160.80M | 217.70M | -226.00M | -163.40M | -77.90M | Total Liabilities |
1.18B | 1.18B | 1.10B | 713.30M | 596.90M | 550.80M | Stockholders Equity |
926.10M | 926.10M | 968.30M | 1.04B | 889.40M | 884.70M |
Cash Flow | Free Cash Flow | ||||
287.55M | 146.80M | 97.00M | 104.40M | 102.10M | 46.60M | Operating Cash Flow |
392.90M | 243.10M | 206.00M | 188.70M | 181.60M | 156.00M | Investing Cash Flow |
-122.90M | -99.10M | -464.40M | -81.60M | -53.20M | -185.50M | Financing Cash Flow |
-118.40M | -63.20M | 159.70M | -47.30M | -55.60M | -48.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $46.30B | 24.58 | 17.85% | 1.89% | 14.01% | 6.03% | |
73 Outperform | £2.09B | 15.33 | 14.44% | 2.26% | 10.36% | 32.77% | |
72 Outperform | $68.00B | 26.47 | ― | 14.70% | 3.76% | ||
66 Neutral | £407.55M | 171.97 | 1.82% | 1.37% | 9.11% | ― | |
66 Neutral | £664.96M | 25.63 | 5.59% | 1.53% | 1.41% | -16.76% | |
62 Neutral | $8.27B | 14.03 | 2.36% | 3.08% | 3.85% | -14.32% |